Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Implementation01:15

Nursing Implementation

6.3K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
6.3K
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

4
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
4
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

17
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
17
Role of Communication in the Nursing Process II: Planning and Implementation01:25

Role of Communication in the Nursing Process II: Planning and Implementation

2.7K
Several factors are considered while creating a patient's care plan. Motivation is a factor in improving communication, and patients often require encouragement to try different approaches involving significant change. It is essential to involve the patient and family in decisions about the plan of care to determine whether the suggested methods are acceptable. Consider meeting critical comfort and safety needs before introducing new communication methods and techniques. Allow adequate time...
2.7K
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation01:24

Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation

2.1K
Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
2.1K
Social Traps01:41

Social Traps

27.0K
Social traps are negative situations where people get caught in a direction or relationship that later proves to be unpleasant, with no easy way to back out of or avoid. The concept was orignally introduced by John Platt who applied psychology to Garrett Hardin's "Tragedy of the Commons", where in New England herd owners could let their cattle graze in the common ground. This situation seems like a good idea, but an individual could have an advantage. If they owned...
27.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.

Annals of surgical oncology·2026
Same author

Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.

Annals of surgical oncology·2026
Same author

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same author

Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients.

The American surgeon·2026
Same author

MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.

The Journal of clinical investigation·2026
Same author

Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

Cancer discovery·2026

Related Experiment Video

Updated: Feb 14, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Implementing a Program of Talimogene laherparepvec.

Frances Collichio1, Lauren Burke2, Amber Proctor3

  • 1Division of Hematology-Oncology, Department of Medicine, The University of North Carolina, Chapel Hill, NC, USA. fcollich@med.unc.edu.

Annals of Surgical Oncology
|February 9, 2018
PubMed
Summary
This summary is machine-generated.

This study outlines a systematic approach for administering talimogene laherparepvec (Imlygic®), an oncolytic virus therapy, for advanced melanoma treatment. Implementing this process can enhance patient care quality.

More Related Videos

Designing and Implementing Nervous System Simulations on LEGO Robots
10:34

Designing and Implementing Nervous System Simulations on LEGO Robots

Published on: May 25, 2013

15.7K
Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

21.3K

Related Experiment Videos

Last Updated: Feb 14, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Designing and Implementing Nervous System Simulations on LEGO Robots
10:34

Designing and Implementing Nervous System Simulations on LEGO Robots

Published on: May 25, 2013

15.7K
Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

21.3K

Area of Science:

  • Oncolytic virotherapy
  • Cancer treatment modalities

Background:

  • Oncolytic viruses selectively target and replicate in cancer cells.
  • Talimogene laherparepvec (Imlygic®) is the first approved oncolytic viral therapy for cancer.
  • Approved in 2015, it targets locally advanced melanoma.

Purpose of the Study:

  • To describe a systematic approach for the clinical use of talimogene laherparepvec.
  • To provide a framework for other institutions prescribing this oncolytic viral therapy.
  • To detail pretreatment planning and delivery processes for biologic oncolytic agents.

Main Methods:

  • Review of clinical trial experience with talimogene laherparepvec.
  • Development of a Standard Operating Procedure (SOP) with multidisciplinary input.
  • Reflection on clinical cases and administration procedures to refine the SOP.

Main Results:

  • Detailed description of preimplementation planning, patient selection, and lesion identification.
  • Explanation of the administration procedure and ongoing patient assessment.
  • Identification of tumor-related factors presenting unique challenges.

Conclusions:

  • A structured process for administering talimogene laherparepvec ensures safe and responsible implementation.
  • This program can potentially improve treatment quality for advanced melanoma patients.
  • Standardized protocols are crucial for novel biologic therapies like oncolytic viruses.